192 related articles for article (PubMed ID: 36012307)
21. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.
Daniele S; Zappelli E; Natali L; Martini C; Trincavelli ML
Cell Death Dis; 2014 Nov; 5(11):e1539. PubMed ID: 25429616
[TBL] [Abstract][Full Text] [Related]
22. Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells.
Hu X; Wu N; Xia P; Yu S; Sun F; Chen J
Cancer Chemother Pharmacol; 2012 May; 69(5):1205-12. PubMed ID: 22258403
[TBL] [Abstract][Full Text] [Related]
23. Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells.
Jin F; Zhao L; Guo YJ; Zhao WJ; Zhang H; Wang HT; Shao T; Zhang SL; Wei YJ; Feng J; Jiang XB; Zhao HY
Brain Res; 2010 Jun; 1336():103-11. PubMed ID: 20388502
[TBL] [Abstract][Full Text] [Related]
24. Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines.
Declèves X; Fajac A; Lehmann-Che J; Tardy M; Mercier C; Hurbain I; Laplanche JL; Bernaudin JF; Scherrmann JM
Int J Cancer; 2002 Mar; 98(2):173-80. PubMed ID: 11857404
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells.
Colwell N; Larion M; Giles AJ; Seldomridge AN; Sizdahkhani S; Gilbert MR; Park DM
Neuro Oncol; 2017 Jul; 19(7):887-896. PubMed ID: 28339582
[TBL] [Abstract][Full Text] [Related]
26. Short-Term Differentiation of Glioblastoma Stem Cells Induces Hypoxia Tolerance.
Skjellegrind HK; Fayzullin A; Johnsen EO; Eide L; Langmoen IA; Moe MC; Vik-Mo EO
Neurochem Res; 2016 Jul; 41(7):1545-58. PubMed ID: 26915110
[TBL] [Abstract][Full Text] [Related]
27. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression.
Papale M; Buccarelli M; Mollinari C; Russo MA; Pallini R; Ricci-Vitiani L; Tafani M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290386
[TBL] [Abstract][Full Text] [Related]
29. Involvement of CD73 and A2B Receptor in Radiation-Induced DNA Damage Response and Cell Migration in Human Glioblastoma A172 Cells.
Kitabatake K; Kaji T; Tsukimoto M
Biol Pharm Bull; 2021 Feb; 44(2):197-210. PubMed ID: 33268695
[TBL] [Abstract][Full Text] [Related]
30. PLGA-Nano-Encapsulated Disulfiram Inhibits Hypoxia-Induced NF-κB, Cancer Stem Cells, and Targets Glioblastoma In Vitro and In Vivo.
Kannappan V; Liu Y; Wang Z; Azar K; Kurusamy S; Kilari RS; Armesilla AL; Morris MR; Najlah M; Liu P; Bian XW; Wang W
Mol Cancer Ther; 2022 Aug; 21(8):1273-1284. PubMed ID: 35579893
[TBL] [Abstract][Full Text] [Related]
31. M2 Receptor Activation Counteracts the Glioblastoma Cancer Stem Cell Response to Hypoxia Condition.
Cristofaro I; Limongi C; Piscopo P; Crestini A; Guerriero C; Fiore M; Conti L; Confaloni A; Tata AM
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32131421
[TBL] [Abstract][Full Text] [Related]
32. HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia.
Yang M; Ma C; Liu S; Shao Q; Gao W; Song B; Sun J; Xie Q; Zhang Y; Feng A; Liu Y; Hu W; Qu X
Immunol Cell Biol; 2010 Feb; 88(2):165-71. PubMed ID: 19841638
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
Yang W; Wei J; Guo T; Shen Y; Liu F
Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
[TBL] [Abstract][Full Text] [Related]
35. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
Shin HJ; Lee S; Jung HJ
J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
[TBL] [Abstract][Full Text] [Related]
36. Targeting A20 decreases glioma stem cell survival and tumor growth.
Hjelmeland AB; Wu Q; Wickman S; Eyler C; Heddleston J; Shi Q; Lathia JD; Macswords J; Lee J; McLendon RE; Rich JN
PLoS Biol; 2010 Feb; 8(2):e1000319. PubMed ID: 20186265
[TBL] [Abstract][Full Text] [Related]
37. Interactions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis.
Rizvi YQ; Mehta CS; Oyekan A
Vascul Pharmacol; 2013; 59(5-6):144-51. PubMed ID: 24050945
[TBL] [Abstract][Full Text] [Related]
38. The Adenosine A
Knowles HJ
Cells; 2019 Jun; 8(6):. PubMed ID: 31234425
[TBL] [Abstract][Full Text] [Related]
39. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
40. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma].
Bi CL; Fang JS; Chen FH; Wang YJ; Wu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]